Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Epidemiological Prospective Cohort Study to Describe Treatment Patterns of Fulvestrant And ExemeSTane in Postmenopausal Patients With Advanced HR+ Breast Cancer Under Real-life Conditions in GERmany

NCT01171417 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01171417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01171417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Epidemiological Prospective Cohort Study to Describe Treatment Patterns of Fulvestrant And ExemeSTane in Postmenopausal Patients With Advanced HR+ Breast Cancer Under Real-life Conditions in GERmany
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
November 30, 2013
Enrollment
570 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, postmenopause